

| Número de catálogo | HS858035 |
|---|---|
| Descripción |
Anti-Human HIF1A Monoclonal Antibody (1A714) [1A714] (HS858035) is a mouse monoclonal antibody detecting HIF1A in ELISA, IHC, WB. Suitable for Human.
Highlights
|
| Reactividad de especies | Human |
| Aplicaciones | ELISA, IHC, WB |
| Especie huésped | Mouse |
| Clonalidad | Monoclonal |
| Isotipo | IgG |
| ID de clon | 1A714 |
| Inmunógeno | E. coli - derived recombinant human HIF1A (Asp55-Val342). |
| Objetivo | Hypoxia-inducible factor 1-alpha, HIF-1-alpha, HIF1-alpha, ARNT-interacting protein, Basic-helix-loop-helix-PAS protein MOP1, Class E basic helix-loop-helix protein 78, bHLHe78, Member of PAS protein 1, PAS domain-containing protein 8, HIF1A |
| Purificación | Protein A/G purified from cell culture supernatant. |
| Número de acceso | Q16665 |
| Forma | Liquid |
| Buffer de almacenamiento | 0.01M PBS pH 7.4 Consulte la información específica del buffer en la copia impresa del datasheet o en el COA específico del lote. |
| Estabilidad y almacenamiento | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Fondo | Hypoxia-inducible factor 1-alpha (HIF1A) is a ~92 kDa protein. Functions as a master transcriptional regulator of the adaptive response to hypoxia. Under hypoxic conditions, activates the transcription of over 40 genes, including erythropoietin, glucose transporters, glycolytic enzymes, vascular endothelial growth factor, HILPDA, and other genes whose protein products increase oxygen delivery or facilitate metabolic adaptation to hypoxia. Plays an essential role in embryonic vascularization, tumor angiogenesis and pathophysiology of ischemic disease. Heterodimerizes with ARNT; heterodimer binds to core DNA sequence 5'-TACGTG-3' within the hypoxia response element (HRE) of target gene promoters. Activation requires recruitment of transcriptional coactivators such as CREBBP and EP300. 1. Jaakkola, P. et al. (2001) Science (New York, N.Y.) 292, 468-72. PMID: 11292861 2. Masson, N. et al. (2001) The EMBO journal 20, 5197-206. PMID: 11566883 3. Bae, SH. et al. (2004) Biochemical and biophysical research communications 324, 394-400. PMID: 15465032 4. Choi, SM. et al. (2006) The Journal of biological chemistry 281, 34056-63. PMID: 16973622 5. Berta, MA. et al. (2007) Biochemical and biophysical research communications 360, 646-52. PMID: 17610843 6. Kim, EJ. et al. (2008) Arteriosclerosis, thrombosis, and vascular biology 28, 1796-802. PMID: 18658046 7. Gimm, T. et al. (2010) FASEB journal : official publication of the Federation of American Societies for Experimental Biology 24, 4443-58. PMID: 20624928 8. Shan, B. et al. (2012) Endocrine-related cancer 19, 13-27. PMID: 22009797 9. Xu, C. et al. (2018) PLoS pathogens 14, e1007259. PMID: 30125331 10. Bhattacharya, S. et al. (1999) Genes & development 13, 64-75. PMID: 9887100 |
| Nota | For research use only. |

SDS-PAGE for Anti-Human HIF1A Monoclonal Antibody (1A714)




Contáctenos para cotizaciones personalizadas, solicitudes en masa y cualquier otro problema.
Correo: [email protected]


+86-027-65523339
Edificio C, No. 666, Calle Shendunsi, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский